skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > ion > anion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > ion > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > polyatomic entity > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxide > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > ion > anion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > ion > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > alpha-n-neu5ac-(2->3)-beta-d-gal-(1->4)-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)

اصطلاح مرجح

n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fuc-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))(1-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • -1

فرمول

  • C78H132N4O45R

والد-عملکردی دارد

جرم

  • 1845.886

جرم تک‌ایزوتوپی

  • 1844.81636

اسمایلٓ

  • [C@H]1(O[C@@H]([C@@H]([C@@H]([C@H]1O)O[C@]2(O[C@]([C@@H]([C@H](C2)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)O)CO)O[C@H]3[C@@H]([C@H]([C@@H](O[C@@H]3CO)O[C@@H]4[C@H]([C@@H](O[C@@H]([C@@H]4O)CO)O[C@H]5[C@@H]([C@H]([C@@H](O[C@@H]5CO)O[C@@H]6[C@H]([C@@H](O[C@@H]([C@@H]6O)CO)O[C@H]7[C@@H]([C@H]([C@@H](O[C@@H]7CO)OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCCCC)O)NC(=O)*)O)O)O)NC(C)=O)O[C@@H]8O[C@H]([C@H]([C@H]([C@@H]8O)O)O)C)O)NC(=O)C)O

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • alpha-NeuNAc-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d20:1(4E))(1-)
  • a neolactoside VI(3)-alpha-NeuAc,III(3)-alpha-Fuc-nLc6Cer(d20:1(4E))
  • N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-eicosasphing-4-enine(1-)
  • N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-icosasphingosine(1-)

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:144934

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD